Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia

被引:35
作者
Younger, JG
Shankar-Sinha, S
Mickiewicz, M
Brinkman, AS
Valencia, GA
Sarma, JV
Younkin, EM
Standiford, TJ
Zetoune, FS
Ward, PA
机构
[1] Univ Michigan, Dept Emergency Med, Ann Arbor, MI USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI USA
关键词
D O I
10.1165/rcmb.2002-0145OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complement is necessary for defense against lung infection with Pseudomonas aeruginosa in mice. We studied in vitro interactions between complement and P. aeruginosa and in vivo effects of complement depletion to better understand this relationship. In vitro, P. aeruginosa strain UI-18 was resistant to killing by mouse serum. However, C3 opsonized the organism (via the alternative and mannose binding lectin [MBL] pathways), and C5 convertase activity on the bacterial surface was demonstrated. In vivo, compared with normal mice, complement-deficient mice experienced higher mortality and failed to sterilize their bronchoalveolar space within 24 h of inoculation. These changes did not seem to be a result of decreased inflammation because complement-deficient mice had normal neutrophil recruitment, greater lung myeloperoxidase content, and, by 24 h, a 35-fold higher level of the CXC chemokine KC. Lung static pressure-volume curves were abnormal in infected animals but were significantly more so in complement deficient mice. These data indicate that although P. aeruginosa is resistant to serum killing, C3 opsonization and C5 convertase assembly occur on its surface. This interaction in vivo plays a central role in host survival beyond just recruitment and activation of phagocytes and may serve to limit the inflammatory response to and tissue injury resulting from bacterial infection.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 25 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]  
Botto M, 2000, COMPLEMENT FACTS BOO, P88
[3]   LUNG DEFENSES AGAINST PSEUDOMONAS-AERUGINOSA IN C5-DEFICIENT MICE WITH DIFFERENT GENETIC BACKGROUNDS [J].
CERQUETTI, MC ;
SORDELLI, DO ;
BELLANTI, JA ;
HOOKE, AM .
INFECTION AND IMMUNITY, 1986, 52 (03) :853-857
[4]   Protective effects of C5a blockade in sepsis [J].
Czermak, BJ ;
Sarma, V ;
Pierson, CL ;
Warner, RL ;
Huber-Lang, M ;
Bless, NM ;
Schmal, H ;
Friedl, HP ;
Ward, PA .
NATURE MEDICINE, 1999, 5 (07) :788-792
[5]   Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass [J].
Fitch, JCK ;
Rollins, S ;
Matis, L ;
Alford, B ;
Aranki, S ;
Collard, CD ;
Dewar, M ;
Elefteriades, J ;
Hines, R ;
Kopf, G ;
Kraker, P ;
Li, L ;
O'Hara, R ;
Rinder, C ;
Rinder, H ;
Shaw, R ;
Smith, B ;
Stahl, G ;
Shernan, SK .
CIRCULATION, 1999, 100 (25) :2499-2506
[6]   Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis [J].
Garred, P ;
Pressler, T ;
Madsen, HO ;
Frederiksen, B ;
Svejgaard, A ;
Hoiby, N ;
Schwartz, M ;
Koch, C .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :431-437
[7]   Complement receptor 1/CD35 is a receptor for mannan-binding lectin [J].
Ghiran, I ;
Barbashov, SF ;
Klickstein, LB ;
Tas, S ;
Jensenius, JC ;
Nicholson-Weller, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1797-1807
[8]   EFFECT OF COMPLEMENT DEPLETION ON LUNG CLEARANCE OF BACTERIA [J].
GROSS, GN ;
REHM, SR ;
PIERCE, AK .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (02) :373-378
[9]   The C5a chemoattractant receptor mediates mucosal defence to infection [J].
Hopken, UE ;
Lu, B ;
Gerard, NP ;
Gerard, C .
NATURE, 1996, 383 (6595) :86-89
[10]   Generation of C5a by phagocytic cells [J].
Huber-Lang, M ;
Younkin, EM ;
Sarma, JV ;
Riedemann, N ;
McGuire, SR ;
Lu, KT ;
Kunkel, R ;
Younger, JG ;
Zetoune, FS ;
Ward, PA .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) :1849-1859